Hilary Daniel, BS; Lois Snyder Sulmasy, JD; for the Health and Public Policy Committee of the American College of Physicians *
Financial Support: Financial support for the development of this paper comes exclusively from the ACP operating budget.
Disclosures: Authors have disclosed no conflicts of interest. Authors followed the policy regarding conflicts of interest described at www.annals.org/article.aspx?articleid=745942. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-0498.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer.
Requests for Single Reprints: Hilary Daniel, BS, American College of Physicians, 25 Massachusetts Avenue NW, Suite 700, Washington, DC 20001; e-mail, firstname.lastname@example.org.
Current Author Addresses: Ms. Daniel: American College of Physicians, 25 Massachusetts Avenue NW, Suite 700, Washington, DC 20001.
Ms. Snyder Sulmasy: American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19160.
Author Contributions: Conception and design: H. Daniel, D.M. DeLong, M.W. Beachy, G.A. Hood, G.C. Kane, A. Minaei.
Analysis and interpretation of the data: J.F. Bush, A. Minaei.
Drafting of the article: L. Snyder Sulmasy.
Critical revision of the article for important intellectual content: H. Daniel, L. Snyder Sulmasy, T. Tape, D.M. DeLong, M.W. Beachy, T. Henry, G.A. Hood, R.H. Lohr, A. Minaei, D.V. Moyer, S. Rehman.
Final approval of the article: H. Daniel, L. Snyder Sulmasy, T. Tape, D.M. DeLong, M.W. Beachy, S.S. Bornstein, J.F. Bush, T. Henry, G.A. Hood, G.C. Kane, R.H. Lohr, A. Minaei, D.V. Moyer, K.E. Olive, S. Rehman.
Administrative, technical, or logistic support: S.S. Bornstein.
Telemedicine—the use of technology to deliver care at a distance—is rapidly growing and can potentially expand access for patients, enhance patient–physician collaboration, improve health outcomes, and reduce medical costs. However, the potential benefits of telemedicine must be measured against the risks and challenges associated with its use, including the absence of the physical examination, variation in state practice and licensing regulations, and issues surrounding the establishment of the patient–physician relationship. This paper offers policy recommendations for the practice and use of telemedicine in primary care and reimbursement policies associated with telemedicine use. The positions put forward by the American College of Physicians highlight a meaningful approach to telemedicine policies and regulations that will have lasting positive effects for patients and physicians.
Daniel H, Sulmasy LS, for the Health and Public Policy Committee of the American College of Physicians. Policy Recommendations to Guide the Use of Telemedicine in Primary Care Settings: An American College of Physicians Position Paper. Ann Intern Med. 2015;163:787–789. [Epub ahead of print 8 September 2015]. doi: https://doi.org/10.7326/M15-0498
Download citation file:
Published: Ann Intern Med. 2015;163(10):787-789.
Published at www.annals.org on 8 September 2015
Healthcare Delivery and Policy.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use